Polymerase chain reaction-based "pre-emptive" therapy with cidofovir for cytomegalovirus reactivation in allogeneic hematopoietic stem cells transplantation recipients: a prospective study.
Bosi
Alberto
A
Bartolozzi
Benedetta
B
Vannucchi
Alessandro M
AM
Orsi
Alessandra
A
Guidi
Stefano
S
Rossi Ferrini
Pierluigi
P
D000328:Adult; D000077404:Cidofovir; D003587:Cytomegalovirus / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control*; D003596:Cytosine / Q000008:administration & dosage* / Q000031:analogs & derivatives; D004279:DNA, Viral / Q000097:blood; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D008875:Middle Aged; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage*; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D014775:Virus Activation / Q000187:drug effects
D004279:DNA, Viral; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir